A new multi-center study shows that an experimental drug lowers prostate specific antigen levels -- a marker for tumor growth -- in men with advanced prostate cancer for whom traditional treatment options have failed.
Full article >>
Monday, April 13, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment